Ataga KI - Search Results

1

Real-world experience using hydroxyurea in children with sickle cell disease in Lilongwe, Malawi.

Mvalo T, Topazian HM, Kamthunzi P, Chen JS, Kambalame I, Mafunga P, Mumba N, Chiume M, Paseli K, Tegha G, Kumwenda W, Heimlich JB, Ellis G, Key N, Gopal S, Hoffman I, Ataga KI, Westmoreland KD. Mvalo T, et al. Among authors: ataga ki. Pediatr Blood Cancer. 2019 Nov;66(11):e27954. doi: 10.1002/pbc.27954. Epub 2019 Aug 9. Pediatr Blood Cancer. 2019. PMID: 31397075 Free PMC article.

2

Renal abnormalities in sickle cell disease.

Ataga KI, Orringer EP. Ataga KI, et al. Am J Hematol. 2000 Apr;63(4):205-11. doi: 10.1002/(sici)1096-8652(200004)63:4<205::aid-ajh8>3.0.co;2-8. Am J Hematol. 2000. PMID: 10706765 Free article. Review.

3

Pulmonary hypertension in sickle cell disease.

Ataga KI, Sood N, De Gent G, Kelly E, Henderson AG, Jones S, Strayhorn D, Lail A, Lieff S, Orringer EP. Ataga KI, et al. Am J Med. 2004 Nov 1;117(9):665-9. doi: 10.1016/j.amjmed.2004.03.034. Am J Med. 2004. PMID: 15501204

4

Pulmonary hypertension in patients with sickle cell disease: a longitudinal study.

Ataga KI, Moore CG, Jones S, Olajide O, Strayhorn D, Hinderliter A, Orringer EP. Ataga KI, et al. Br J Haematol. 2006 Jul;134(1):109-15. doi: 10.1111/j.1365-2141.2006.06110.x. Br J Haematol. 2006. PMID: 16803576 Free article.

5

Hypercoagulability in sickle cell disease: new approaches to an old problem.

Ataga KI, Key NS. Ataga KI, et al. Hematology Am Soc Hematol Educ Program. 2007:91-6. doi: 10.1182/asheducation-2007.1.91. Hematology Am Soc Hematol Educ Program. 2007. PMID: 18024615 Review.

6

Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia.

Ataga KI, Smith WR, De Castro LM, Swerdlow P, Saunthararajah Y, Castro O, Vichinsky E, Kutlar A, Orringer EP, Rigdon GC, Stocker JW; ICA-17043-05 Investigators. Ataga KI, et al. Blood. 2008 Apr 15;111(8):3991-7. doi: 10.1182/blood-2007-08-110098. Epub 2008 Jan 11. Blood. 2008. PMID: 18192510 Free article. Clinical Trial.

7

Hypercoagulability in sickle cell disease and beta-thalassemia.

Singer ST, Ataga KI. Singer ST, et al. Among authors: ataga ki. Curr Mol Med. 2008 Nov;8(7):639-45. doi: 10.2174/156652408786241366. Curr Mol Med. 2008. PMID: 18991650 Review.

8

Placenta growth factor in sickle cell disease: association with hemolysis and inflammation.

Brittain JE, Hulkower B, Jones SK, Strayhorn D, De Castro L, Telen MJ, Orringer EP, Hinderliter A, Ataga KI. Brittain JE, et al. Among authors: ataga ki. Blood. 2010 Mar 11;115(10):2014-20. doi: 10.1182/blood-2009-04-217950. Epub 2009 Dec 29. Blood. 2010. PMID: 20040765 Free PMC article.

9

Delayed hemolytic transfusion reaction in sickle cell disease.

Scheunemann LP, Ataga KI. Scheunemann LP, et al. Among authors: ataga ki. Am J Med Sci. 2010 Mar;339(3):266-9. doi: 10.1097/MAJ.0b013e3181c70e14. Am J Med Sci. 2010. PMID: 20051821 Free PMC article. Review.

10

Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease.

Ataga KI, Brittain JE, Jones SK, May R, Delaney J, Strayhorn D, Desai P, Redding-Lallinger R, Key NS, Orringer EP. Ataga KI, et al. Br J Haematol. 2011 Feb;152(4):485-91. doi: 10.1111/j.1365-2141.2010.08410.x. Epub 2011 Jan 11. Br J Haematol. 2011. PMID: 21223248 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page